Michael J. McElhaugh, Interim President & CEO: Arbutus Biopharma ABUS Planned sale · Filed 25/04/21

Trade details

Type: Planned sale notice
Stock: Arbutus Biopharma ABUS
Person: Michael J. McElhaughInterim President & CEO
Planned sale date: 25/04/21
Filed: 25/04/21

More to sell after $170.1K in 3 months

Arbutus Biopharma trades, last 26 weeks

What else happened in Arbutus Biopharma around then

Filed or reported within 30 days of the trade day · 25/03/22~25/05/21

Michael J. McElhaugh's recent trades

Michael J. McElhaughInterim President & CEO
Planned saleArbutus Biopharma
Planned sale
Arbutus Biopharma
ABUS
$170.1K
53,114 sh
$170.1K
Filed 25/04/15
Traded 25/04/15
Michael J. McElhaughInterim President & CEO
Sell10b5-1 planArbutus Biopharma
Sell10b5-1 plan
Arbutus Biopharma
ABUS
$78K
23,790 sh
$78K
Filed 25/02/05
Traded 25/02/04
J. McElhaugh MichaelDirector and Officer
Planned sale10b5-1 planArbutus Biopharma
Planned sale10b5-1 plan
Arbutus Biopharma
ABUS
$78.1K
23,790 sh
$78.1K
Filed 25/02/04
Traded 25/02/04
Michael J. McElhaughInterim President & CEO
Sell10b5-1 planArbutus Biopharma
Sell10b5-1 plan
Arbutus Biopharma
ABUS
$23.5K
10,164 sh
$23.5K
Filed 24/02/05
Traded 24/02/02

Michael J. McElhaugh, CEO — plans to sell 246,886 sh of Arbutus Biopharma ABUS · $804.9K · around 04/21 | Whalegun